These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 7896956)

  • 1. Antigen processing: the gateway to the immune response.
    Kalish RS
    J Am Acad Dermatol; 1995 Apr; 32(4):640-52. PubMed ID: 7896956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Molecular basis for detection of infectious agents].
    Siegrist CA
    Schweiz Med Wochenschr; 1996 Feb; 126(7):246-54. PubMed ID: 8720322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
    Li Y; Ke Y; Gottlieb PD; Kapp JA
    J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanoma-specific CD4+ T lymphocytes recognize human melanoma antigens processed and presented by Epstein-Barr virus-transformed B cells.
    Topalian SL; Rivoltini L; Mancini M; Ng J; Hartzman RJ; Rosenberg SA
    Int J Cancer; 1994 Jul; 58(1):69-79. PubMed ID: 7516926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HLA system, antigen processing and presentation.
    Krensky AM
    Kidney Int Suppl; 1997 Mar; 58():S2-7. PubMed ID: 9067934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigen presentation pathways to class I and class II MHC-restricted T lymphocytes.
    Braciale TJ; Morrison LA; Sweetser MT; Sambrook J; Gething MJ; Braciale VL
    Immunol Rev; 1987 Aug; 98():95-114. PubMed ID: 2443444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Priming of T cells by exogenous antigen cross-presented on MHC class I molecules.
    Shen L; Rock KL
    Curr Opin Immunol; 2006 Feb; 18(1):85-91. PubMed ID: 16326087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophils process exogenous bacteria via an alternate class I MHC processing pathway for presentation of peptides to T lymphocytes.
    Potter NS; Harding CV
    J Immunol; 2001 Sep; 167(5):2538-46. PubMed ID: 11509593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Class II MHC antigen processing in immune tolerance and inflammation.
    Jurewicz MM; Stern LJ
    Immunogenetics; 2019 Mar; 71(3):171-187. PubMed ID: 30421030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified vaccinia virus Ankara-infected dendritic cells present CD4+ T-cell epitopes by endogenous major histocompatibility complex class II presentation pathways.
    Thiele F; Tao S; Zhang Y; Muschaweckh A; Zollmann T; Protzer U; Abele R; Drexler I
    J Virol; 2015 Mar; 89(5):2698-709. PubMed ID: 25520512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation.
    Hegde NR; Tomazin RA; Wisner TW; Dunn C; Boname JM; Lewinsohn DM; Johnson DC
    J Virol; 2002 Nov; 76(21):10929-41. PubMed ID: 12368336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens.
    Schirrmacher V; Schild HJ; Gückel B; von Hoegen P
    Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative pathways for processing exogenous and endogenous antigens that can generate peptides for MHC class I-restricted presentation.
    Reimann J; Schirmbeck R
    Immunol Rev; 1999 Dec; 172():131-52. PubMed ID: 10631943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-presentation: underlying mechanisms and role in immune surveillance.
    Rock KL; Shen L
    Immunol Rev; 2005 Oct; 207():166-83. PubMed ID: 16181335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mouse Schwann cells activate MHC class I and II restricted T-cell responses, but require external peptide processing for MHC class II presentation.
    Meyer zu Hörste G; Heidenreich H; Mausberg AK; Lehmann HC; ten Asbroek AL; Saavedra JT; Baas F; Hartung HP; Wiendl H; Kieseier BC
    Neurobiol Dis; 2010 Feb; 37(2):483-90. PubMed ID: 19914379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a human HLA-E-restricted CD8+ T cell subset in volunteers immunized with Salmonella enterica serovar Typhi strain Ty21a typhoid vaccine.
    Salerno-Gonçalves R; Fernandez-Viña M; Lewinsohn DM; Sztein MB
    J Immunol; 2004 Nov; 173(9):5852-62. PubMed ID: 15494539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule modulators of MHC class II antigen presentation: mechanistic insights and implications for therapeutic application.
    Call MJ
    Mol Immunol; 2011 Sep; 48(15-16):1735-43. PubMed ID: 21676462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.